Cite
HARVARD Citation
Yoshino, T. et al. (2017). Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial. European journal of cancer. pp. 61-69. [Online].